WIRB-Copernicus Group (WCG) clinical service division’s acquisition of Velos eResearch will give WCG’s network access to clinical research simplification capabilities through clinical trial management software.
Velos eResearch manages institutional research by housing study status, patient enrollment, calendars, budgets, billing, and electronic data capture in one place. The company states the platform increases efficiency, transparency and accessibility of institutional research.
According to WCG, it partners with 93% of institutions and 90% of the academic medical centers that conduct research in the US. Donald Deieso, executive chairman and CEO of WCG, stated that the group serves more than 2,800 institutions.
Through this partnership with the institutions, WCG states it facilitates drug development, providing solutions to increase efficiency and profitability of their research, as well as accelerating patient enrollment.
John McIlwain, co-founder and CEO of Velos, said that its clients are a “critical part of the clinical research ecosystem. It is our mission to break down the silos and administrative barriers slowing their progress and limiting their growth, to enable them to accelerate breakthroughs in clinical care.”
Velos will operate independently and retain its headquarters in Fremont, California. WCG will support Velos with access to capital, expertise and corporate operational support.